RecruitingPhase 2NCT06701812
Digoxin Medulloblastoma Study
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Principal Investigator
- Laura Metrock, MDUniversity of Alabama at Birmingham Children's of Alabama
- Intervention
- Digoxin(drug)
- Enrollment
- 23 target
- Eligibility
- 30 years · All sexes
- Timeline
- 2026 – 2027
Study locations (15)
- University of Alabama at Birmingham Children's of Alabama, Birmingham, Alabama, United States
- Arkansas Childrens Hospital, Little Rock, Arkansas, United States
- Connecticut Children's Medical Center, Hartford, Connecticut, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Nemours Jacksonville, Jacksonville, Florida, United States
- University of Miami, Miami, Florida, United States
- Johns Hopkins All Children's, St. Petersburg, Florida, United States
- St. Joseph's Children's Hospital, Tampa, Florida, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
- Washington University St. Louis, St Louis, Missouri, United States
- Montefiore Medical Center, The Bronx, New York, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- Levine Cancer Institute, Charlotte, North Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- UT Southwestern, Dallas, Texas, United States
Collaborators
National Pediatric Cancer Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06701812 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS
- ENROLLING BY INVITATIONNCT06814353Intraoperatively Observed Site of Origin and Growth Pattern of MedulloblastomaChristian Dorfer